Colombia vs Iran: Cause of death, by non-communicable diseases, ages 0-4, female
Colombia
35.7%
in 2021
Iran
36.2%
in 2021
Colombia rank
68th
Iran rank
65th
Cause of death, by non-communicable diseases, ages 0-4, female over time
- Colombia
- Iran
How they compare
Iran currently reports 36.2% against 35.7% in Colombia, a difference of 0.5%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Colombia ahead.
Colombia ranks 68th and Iran ranks 65th of 185 countries.
Across the 3 decades both report, Colombia averaged higher in 2 and Iran in 1.
Head to head by decade
| Decade | Colombia | Iran | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 22.8% | 22.2% | 0.6% | Colombia |
| 2010s | 34.5% | 33.6% | 0.8% | Colombia |
| 2020s | 35.2% | 36.4% | 1.1% | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, Colombia or Iran?
- Iran, at 36.2% against 35.7% in Colombia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between Colombia and Iran?
- 0.5%, with Iran ahead.
- How many years of comparable data are there for Colombia and Iran?
- 6 years are reported by both, from 2000 to 2021.
- How do Colombia and Iran rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- Colombia ranks 68th and Iran ranks 65th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.